Resistance to cancer therapy via upregulation of the NRP2/VEGF-C axis can be neutralized by ATYR2810

ATYR2810 - aTyr Pharma

cisplatin - Generic mfg.

Sutent (sunitinib) - Pfizer

https://www.abstractsonline.com/pp8/#!/10828/presentation/9346

Alison Barber; Zhiwen Xu; Lisa Eide; Clara Polizzi; Max Pastenes; Lauren Guy; Jasmine Stamps; Kristina Hamel; Zachary Fogassy; Sofia Klopp-Savino; Esther Chong; Yang Qing; Lara Glendening; Christoph Burkart; Leslie Nangle

Mar 14, 2023